Israel China Biotechnology (ICB) Ltd
Silver Castle Holdings Ltd operates as a healthcare investment company. It invests in companies in the biomedical field in Israel. The company was formerly known as Israel China Biotechnology (ICB) Ltd and changed its name to Silver Castle Holdings Ltd in February 2022. Silver Castle Holdings Ltd was founded in 2000 and is based in Tel Aviv, Israel.
Israel China Biotechnology (ICB) Ltd (ICB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2021: -0.415x
Based on the latest financial reports, Israel China Biotechnology (ICB) Ltd (ICB) has a cash flow conversion efficiency ratio of -0.415x as of June 2021.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.06 Million) by net assets (ILA2.55 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Israel China Biotechnology (ICB) Ltd - Cash Flow Conversion Efficiency Trend (2015–2020)
This chart illustrates how Israel China Biotechnology (ICB) Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Israel China Biotechnology (ICB) Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Israel China Biotechnology (ICB) Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
UBuyHoldings Inc
PINK:UBYH
|
0.220x |
|
Tongyang Inc. Pfd. Series 2
KQ:001527
|
N/A |
|
BTTCD
OTCQB:BTTCD
|
N/A |
|
Oyang Corp.
KQ:006090
|
N/A |
|
AS Harju Elekter
STU:HD8
|
0.099x |
|
Hollywood Bowl Group PLC
LSE:BOWL
|
0.215x |
|
Rank Group PLC
LSE:RNK
|
0.130x |
|
INFORMATION SVC GRP
BE:ZZG
|
0.023x |
Annual Cash Flow Conversion Efficiency for Israel China Biotechnology (ICB) Ltd (2015–2020)
The table below shows the annual cash flow conversion efficiency of Israel China Biotechnology (ICB) Ltd from 2015 to 2020.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2020-12-31 | ILA470.00K | ILA-4.34 Million | -9.232x | -312.74% |
| 2019-12-31 | ILA1.89 Million | ILA-4.22 Million | -2.237x | -248.93% |
| 2018-12-31 | ILA7.41 Million | ILA-4.75 Million | -0.641x | -134.10% |
| 2017-12-31 | ILA-1.69 Million | ILA-3.17 Million | 1.880x | +190.81% |
| 2016-12-31 | ILA1.91 Million | ILA-3.94 Million | -2.070x | -213.83% |
| 2015-12-31 | ILA5.78 Million | ILA-3.81 Million | -0.660x | -- |